Diversified Trust CO Gilead Sciences, Inc. Transaction History

Diversified Trust CO

$3.3 Billion
Q4 2024

A detailed history of Diversified Trust CO transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Diversified Trust CO holds 34,455 shares of GILD stock, worth $3.16 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

34,455

Previous 33,436 3.05%

Holding current value

$3.16 Million

Previous $2.8 Million 13.56%

% of portfolio

0.1%

Previous 0.09%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 07, 2025	BUY	$83.95 - $97.9 $85,545 - $99,760	1,019 Added 3.05%	34,455 $3.18 Million
Q3 2024 Oct 07, 2024	BUY	$66.59 - $83.99 $29,898 - $37,711	449 Added 1.36%	33,436 $2.8 Million
Q2 2024 Jul 16, 2024	BUY	$63.15 - $72.88 $219,951 - $253,841	3,483 Added 11.81%	32,987 $2.26 Million
Q1 2024 Apr 18, 2024	SELL	$71.58 - $87.29 $229,127 - $279,415	-3,201 Reduced 9.79%	29,504 $2.16 Million
Q4 2023 Jan 08, 2024	SELL	$73.27 - $83.09 $356,092 - $403,817	-4,860 Reduced 12.94%	32,705 $2.65 Million
Q3 2023 Nov 17, 2023	SELL	$73.94 - $80.67 $398,758 - $435,053	-5,393 Reduced 12.55%	37,565 $2.82 Million
Q2 2023 Jul 18, 2023	SELL	$76.01 - $86.7 $7,981 - $9,103	-105 Reduced 0.24%	42,958 $3.31 Million
Q1 2023 Apr 07, 2023	BUY	$77.31 - $88.08 $136,297 - $155,285	1,763 Added 4.27%	43,063 $3.57 Million
Q4 2022 Jan 17, 2023	BUY	$62.32 - $89.47 $373,421 - $536,104	5,992 Added 16.97%	41,300 $3.55 Million
Q3 2022 Oct 14, 2022	BUY	$59.54 - $68.01 $37,629 - $42,982	632 Added 1.82%	35,308 $2.18 Million
Q2 2022 Jul 12, 2022	SELL	$57.72 - $65.01 $49,235 - $55,453	-853 Reduced 2.4%	34,676 $2.14 Million
Q1 2022 Apr 07, 2022	BUY	$57.92 - $72.58 $114,797 - $143,853	1,982 Added 5.91%	35,529 $2.11 Million
Q4 2021 Jan 13, 2022	BUY	$64.88 - $73.64 $176,668 - $200,521	2,723 Added 8.83%	33,547 $2.44 Million
Q3 2021 Jan 13, 2022	SELL	$67.69 - $73.03 $149,527 - $161,323	-2,209 Reduced 6.69%	30,824 $2.15 Million
Q2 2021 Jul 20, 2021	BUY	$63.47 - $69.35 $83,209 - $90,917	1,311 Added 4.13%	33,033 $2.28 Million
Q1 2021 May 10, 2021	SELL	$60.0 - $68.46 $69,660 - $79,482	-1,161 Reduced 3.53%	31,722 $2.05 Million
Q4 2020 Jan 08, 2021	SELL	$56.65 - $64.55 $35,576 - $40,537	-628 Reduced 1.87%	32,883 $1.92 Million
Q3 2020 Oct 15, 2020	BUY	$62.1 - $78.08 $228,776 - $287,646	3,684 Added 12.35%	33,511 $2.12 Million
Q2 2020 Jul 07, 2020	BUY	$72.34 - $84.0 $2,314 - $2,688	32 Added 0.11%	29,827 $2.3 Million
Q1 2020 Apr 10, 2020	BUY	$62.63 - $80.22 $37,014 - $47,410	591 Added 2.02%	29,795 $2.23 Million
Q4 2019 Jan 09, 2020	BUY	$61.62 - $67.78 $448,716 - $493,573	7,282 Added 33.22%	29,204 $1.9 Million
Q3 2019 Oct 09, 2019	SELL	$62.51 - $69.0 $132,208 - $145,935	-2,115 Reduced 8.8%	21,922 $1.39 Million
Q2 2019 Jul 12, 2019	SELL	$61.87 - $69.38 $7,919 - $8,880	-128 Reduced 0.53%	24,037 $1.62 Million
Q1 2019 May 22, 2019	BUY	$62.53 - $70.05 $64,468 - $72,221	1,031 Added 4.46%	24,165 $1.57 Million
Q4 2018 Jan 18, 2019	BUY	$60.54 - $79.0 $1.4 Million - $1.83 Million	23,134 New	23,134 $1.45 Million

Others Institutions Holding GILD

# of Institutions

1,941

Shares Held

989M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $115B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Diversified Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Diversified Trust CO with notifications on news.

Account

Diversified Trust CO Gilead Sciences, Inc. Transaction History